Research Snapshot
Berberine
A synthesis of the peer-reviewed evidence for Berberine across metabolism, gut health, cognition and cardiovascular, graded by scientific consensus and reviewed by our Scientific Advisory Board.
See the Research
MetabolismDoes berberine improve metabolic health?
Evidence from 19 studies
What the research shows
Berberine shows significant potential in improving metabolic health by enhancing glucose and lipid metabolism, reducing insulin resistance, aiding in weight management, and modulating gut microbiota. These effects make it a promising candidate for supporting metabolic health, although further large-scale clinical trials are needed to fully understand its mechanisms and long-term efficacy.
View the top studies
European review for medical and pharmacological sciences | M. Rondanelli et al. | 0 | 2023
Randomized Control Trial (RCT)
Oral supplementation of Berberine PhytosomeTM (550 mg/day) significantly improves glycemia, cholesterol, triglycerides, insulin, ApoB/ApoA, and visceral adipose tissue in overweight individuals with impaired fasting blood glucose.
Frontiers in Pharmacology | Yulan Ye et al. | 38, 1 Influential | 2021
Meta Analysis
Berberine alone can improve obesity, hyperlipidemia, reduce insulin resistance, and prevent diabetic encephalopathy.
Metabolism: clinical and experimental | Jun-yi Yin et al. | 606, 28 Influential | 2008
Randomized Control Trial (RCT) , Highly Cited
Berberine is a potent oral hypoglycemic agent with beneficial effects on lipid metabolism in patients with type 2 diabetes mellitus.
Revista Brasileira de Farmacognosia | Aram Khashayar et al. | 11, 1 Influential | 2021
Systematic Review
Berberine shows potential therapeutic effects in treating metabolic diseases and diabetes mellitus, with potential mechanisms of action and drug interactions.
Gut HealthCan berberine promote microbiome health?
Evidence from 17 studies
What the research shows
The evidence supporting berberine's role in promoting microbiome health is broad and consistent but comes almost entirely from animal and mechanistic studies, with one study including a human patient cohort showing reduced microbiota-derived TMAO production. Across models, berberine consistently reshapes gut microbial composition, supports barrier integrity, and favorably shifts microbial metabolites linked to metabolic and inflammatory balance. Overall, the preclinical evidence is strong and consistent, though rigorous controlled human trials specifically on microbiome outcomes remain limited.
View the top studies
Signal Transduction and Targeted Therapy | Shurong Ma, Qian Tong, Yuan Lin | 184 | 2022
Animal Trial , Highly Cited
This study found that oral berberine lowers gut microbiota-derived trimethylamine-N-oxide (TMAO) production by inhibiting bacterial choline-TMA-lyase and host FMO enzymes, and this effect was confirmed not only in mice but also in a cohort of atherosclerotic patients whose gut microbial TMAO-generating capacity decreased with berberine treatment. The findings support a direct human-relevant mechanism by which berberine reshapes gut microbial metabolic output linked to cardiovascular risk.
PLoS ONE | Xu Zhang, Yufeng Zhao, Menghui Zhang | 656 | 2012
Highly Cited
In high-fat diet-fed rats, berberine altered gut microbiota structure alongside reduced food intake, prevention of obesity and insulin resistance, and normalization of inflammatory and metabolic markers linked to microbial dysbiosis. This foundational, highly-cited study established that berberine's metabolic benefits are closely tied to restructuring of the gut microbial community.
Frontiers in Pharmacology | Huantian Cui, Yuzi Cai, Li Wang | 241 | 2018
Animal Trial , Highly Cited
This mouse study showed that berberine improved colitis by rebalancing Treg/Th17 immune cells, an effect that depended on berberine-induced changes in gut microbiota composition, as confirmed through antibiotic depletion and fecal transplant experiments. It provides mechanistic evidence that berberine's immune-modulatory benefits act through the gut microbiome.
International Journal of Biological Sciences | Yalan Dong, Heng Fan, Zhe Zhang | 195 | 2022
Animal Trial , Highly Cited
This study demonstrated that berberine improved intestinal mucosal barrier integrity in a colitis mouse model through microbiota-dependent mechanisms involving the Wnt/β-catenin signaling pathway. Microbiota depletion reversed the protective effects, indicating that gut microbial changes were necessary for berberine's benefits on the intestinal barrier.
CognitionDoes Berberine Enhance Cognitive Performance?
Evidence from 19 studies
What the research shows
Berberine appears to enhance cognitive performance across various models of cognitive impairment, particularly through mechanisms involving the reduction of amyloid-β and tau pathologies, oxidative stress, and neuroinflammation. These findings suggest its potential as a therapeutic agent for cognitive function.
View the top studies
Frontiers in Pharmacology | Yanwei Hao et al. | 4 | 2022
Meta Analysis
Berberine supplementation can lower blood glucose levels and improve learning and memory in diabetes-related cognitive impairment animal models, potentially through regulating glucose and lipid metabolism, improving insulin resistance, and reducing oxidative stress and inflammation.
Journal of integrative medicine | N. Shinjyo et al. | 26, 1 Influential | 2020
Systematic Review
Berberine may help prevent dementia associated with metabolic syndrome by enhancing cognition and preventing brain damage, as well as alleviating risk factors like metabolic dysfunction and cardiovascular, kidney, and liver diseases.
Experimental Gerontology | Min Huang et al. | 116 | 2017
Non-Randomized Control Trial , Animal Trial , Highly Cited
Berberine improves memory impairment in Alzheimer's disease mice by promoting autophagic clearance and inhibiting -amyloid production.
The journal of nutrition, health & aging | Yang Yu et al. | 65, 4 Influential | 2018
Non-Randomized Control Trial , Animal Trial , Rigorous Journal
Berberine significantly improves cognitive deficits and insulin resistance in naturally aging rats, potentially due to its ability to activate the AMPK/SIRT1/PGC-1 pathway in skeletal muscle.
CardiovascularCan berberine help support cardiovascular function?
Evidence from 19 studies
What the research shows
Berberine appears to be a promising natural compound for supporting cardiovascular function through its multifaceted actions on lipid metabolism, oxidative stress, and inflammation. While it shows potential as a therapeutic agent for various cardiovascular conditions, further high-quality research is needed to fully understand its mechanisms and optimize its clinical use.
View the top studies
Nutrients | Jie V. Zhao et al. | 18 | 2021
Randomized Control Trial (RCT) , Very Rigorous Journal
Berberine effectively lowers cholesterol and may increase testosterone in men with hyperlipidemia, suggesting sex-specific effects.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | Yao Qing et al. | 28 | 2018
Randomized Control Trial (RCT) , Rigorous Journal , Controlled experimental study
Berberine therapy reduces myocardial injury in postoperative patients by reducing autophagy and apoptosis through the AMPK/mTOR pathway.
Frontiers in Nutrition | M. Zamani et al. | 4 | 2022
Meta Analysis
Berberine supplementation significantly improves lipid profile, fasting blood glucose balance, obesity parameters, and systolic blood pressure in adults.
Theranostics | Xiaojun Feng et al. | 212 | 2019
Rigorous Journal , Highly Cited
Berberine shows promising therapeutic potential in treating cardiovascular and metabolic diseases, with recent discoveries identifying novel molecular targets and supporting its therapeutic potential.
Reviewed by Experts
Every research snapshot is checked by our independent Scientific Advisory Board: physicians, botanists and pharmacology researchers who verify the evidence grading and its interpretation.
Kerry Hughes
M.Sc., RH(AHG), FDN-P
Ethnobotanist & herbalist; Berkeley Herbal Center; principal at EthnoPharm.
View full profile →Lance Dreher
PhD, Nutritional Counseling
Performance nutrition & conditioning; four decades of applied training science.
View full profile →Dr. Lindsey Faucette
DO, FAAFP
Board-certified in Family & Integrative Medicine; Touro University College of Osteopathic Medicine.
View full profile →Francisco Chacon
PhD, Plant Biology
Botanical natural products & phytochemistry researcher, Penn State University.
View full profile →Meet the full Scientific Advisory Board →
How We Grade Consensus
For each benefit we retrieve the relevant peer-reviewed literature and classify every study by whether its findings support (Yes), partially or conditionally support (Possibly), or do not support (No) the claim. The donut shows the share of studies in each category; N is the number of studies analyzed for that benefit.
Grades reflect the weight and direction of the current evidence, not a guarantee of outcome, and the interpretation is verified by the Scientific Advisory Board.